VIVITROL (naltrexone for extended-release injectable suspension) VIVITROL: A Treatment Option For The Daily Struggle Against Alcohol Dependence. One dose all month long.
Healthcare Professional Site
Prescribing Information
Send to a Friend
Homepage About Vivitrol Links Contact Us SEARCH
Physician Locator
My Path to Recovery


Physician Locator

The Physician Locator is a tool intended to make it easier to locate licensed physicians who have experience in the evaluation, diagnosis and treatment of alcohol dependence.

We will provide the name, address, and telephone number for the physicians who match your search criteria. To make things even easier, we will provide a map to help you find these healthcare professionals. Plus, we'll give you directions.

Please enter your search criteria below.

Search by Area:
ZIP:
OR
City:
AND
State:
Search Radius:
Refine Your Search (optional)
Search by Name:

If you have a specific physician in mind for alcohol dependence treatment, search by entering the first and/or last name.

First Name:
Last Name:
I agree to the Terms of Use

Terms of Use

The Physician Locator is compiled and published by Alkermes, Inc. and Cephalon, Inc. as a reference source of demographic and professional information on individual licensed physicians in the United States who have experience in the treatment of alcohol dependence. The Physician Locator is searchable by zip code or by city and state. Physicians' enrollment and participation in the Physician Locator is voluntary and free of charge and, along with the physician-specific information in the Physician Locator, is based solely on physician responses.

The Physician Locator is provided by Alkermes and Cephalon for use by the medical and addiction treatment communities, potential patients and/or their families in finding information on, and locating, physicians for the treatment of alcohol dependence. Alkermes and Cephalon are not responsible for, and the Physician Locator is not intended as a tool for, verifying the credentials, expertise, abilities or quality of care of any physician included in the Physician Locator.

Inclusion in the Physician Locator does not imply referral, recommendation or endorsement nor does omission in the Physician Locator imply Alkermes' and Cephalon's disapproval. We recommend that, before scheduling an appointment to see any physician, you research the credentials of the physician and satisfy yourself that the physician provides the quality of care desired.

You are prohibited from using, downloading, republishing, selling, duplicating, or "scraping" for commercial or any other purpose whatsoever, the Physician Locator or any of the data listings or other information contained therein, in whole or in part, in any medium whatsoever.

The information from the Physician Locator is provided on an "AS-IS" basis. Cephalon and Alkermes disclaim all warranties, either express or implied, including but not limited to the implied warranties of merchantability and fitness for particular purpose. Without limiting the foregoing, Cephalon and Alkermes do not warrant or represent that the Physician Locator or any part thereof is accurate or complete. You assume full responsibility for the communications with any physician you contact through the Physician Locator. Alkermes and Cephalon shall in no event be liable to you or to anyone for any decision made or action taken by you in the reliance on information provided in the Physician Locator.

Return to the Physician Locator

Important Safety Information
Naltrexone has the capacity to cause hepatocellular injury when given in excessive doses. Naltrexone is contraindicated in acute hepatitis or liver failure, and its use in patients with active liver disease must be carefully considered in light of its hepatotoxic effects. The margin of separation between the apparently safe dose of naltrexone and the dose causing hepatic injury appears to be only five-fold or less. VIVITROL does not appear to be a hepatotoxin at the recommended doses. Patients should be warned of the risk of hepatic injury and advised to seek medical attention if they experience symptoms of acute hepatitis. Use of VIVITROL should be discontinued in the event of symptoms and/or signs of acute hepatitis.
VIVITROL is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL.

Patients should not be actively drinking at the time of initial VIVITROL administration.

Treatment with VIVITROL should be part of a comprehensive management program that includes psychosocial support.